Myocarditis in COVID-19 presenting with cardiogenic shock: a case series.
COVID-19
Cardiogenic shock
Cardiomyopathy
Case series
Myocarditis
Shortness of breath
Journal
European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
19
08
2020
revised:
26
10
2021
accepted:
16
01
2021
entrez:
18
3
2021
pubmed:
19
3
2021
medline:
19
3
2021
Statut:
epublish
Résumé
SARS-CoV2, also known as COVID-19, is a specific strain of coronavirus that is responsible for an ongoing global pandemic. COVID-19 primarily targets the respiratory system via droplet transmission, causing symptoms similar to influenza, including fever, cough, and shortness of breath. It is now known to impact other organ systems, causing significant cardiovascular and gastrointestinal illness, among others. We describe two cases of COVID-19 induced myocarditis presenting with cardiogenic shock. These cases highlight the importance of understanding the lethal cardiac complications of COVID-19 infection, as well as its presentation, diagnosis, pathophysiology, and potential treatment options. These two cases involve patients without underlying cardiovascular disease risk factors who experienced prolonged symptoms of COVID-19 infection. Both patients presented with cardiogenic shock more than one week after symptom onset and diagnosis. These cases demonstrate the late presentation of myocarditis and cardiogenic shock, treated with corticosteroids and inotropes, with subsequent recovery of cardiac function. The cases highlight the importance of recognizing late presentation viral myocarditis secondary to COVID-19 infection, even in patients without underlying cardiac disease.
Sections du résumé
BACKGROUND
BACKGROUND
SARS-CoV2, also known as COVID-19, is a specific strain of coronavirus that is responsible for an ongoing global pandemic. COVID-19 primarily targets the respiratory system via droplet transmission, causing symptoms similar to influenza, including fever, cough, and shortness of breath. It is now known to impact other organ systems, causing significant cardiovascular and gastrointestinal illness, among others.
CASE SUMMARY
METHODS
We describe two cases of COVID-19 induced myocarditis presenting with cardiogenic shock. These cases highlight the importance of understanding the lethal cardiac complications of COVID-19 infection, as well as its presentation, diagnosis, pathophysiology, and potential treatment options. These two cases involve patients without underlying cardiovascular disease risk factors who experienced prolonged symptoms of COVID-19 infection. Both patients presented with cardiogenic shock more than one week after symptom onset and diagnosis. These cases demonstrate the late presentation of myocarditis and cardiogenic shock, treated with corticosteroids and inotropes, with subsequent recovery of cardiac function.
DISCUSSION
CONCLUSIONS
The cases highlight the importance of recognizing late presentation viral myocarditis secondary to COVID-19 infection, even in patients without underlying cardiac disease.
Identifiants
pubmed: 33733043
doi: 10.1093/ehjcr/ytab028
pii: ytab028
pmc: PMC7953948
doi:
Types de publication
Case Reports
Langues
eng
Pagination
ytab028Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Circulation. 2020 Feb 11;141(6):e69-e92
pubmed: 31902242
Heart Rhythm. 2020 Sep;17(9):1463-1471
pubmed: 32387246
Cardiovasc Revasc Med. 2021 Feb;23:107-113
pubmed: 32847728
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Circ Res. 2016 Feb 5;118(3):496-514
pubmed: 26846643